Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Role of Real-World Evidence in CMS Price Ne...
By
Melike Belenli Gümüş
June 28, 2024
Introduction The role of real-world evidence (RWE) in the
The Significant Bias in Nutrition Research Due to Food Composition Variability
Clinical Trial Screening with GPT-4: The RECTIFIER Framework
A New Approach to Cardiovascular Risk Assessment for Statin Therapy
A Cost-Saving Life-Saver: The Impact of Palivizumab in Columbia
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
Enhancing Surgical Recovery Predictions with AI: A New Approach
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Introducing GRACE for Patient-Centric Care
Universal Early Parenting Programmes: Unraveling the Cost-Effectiveness
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
« Previous
1
…
28
29
30
31
32
…
56
Next »